Huilin Xu

5PUBLICATIONS
6CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 16, 2025
Signal stratification of antineoplastic drugs associated with interstitial lung disease: A multi-method signal detection analysis using the FAERS database.

Zilong Gong, Qiong Wang, Ying Huang

|Mar 31, 2023
Assessing the Relationship Between Liver Metastases and the Survival of Patients With Non-Small Cell Lung Cancer After Immune Checkpoint Inhibitors Treatment: A Systematic Review and Meta-Analysis.

Huilin Xu, Pingpo Ming, Zhenyu Zhao

|Jan 23, 2023
Assessing Potential Factors Influencing the Efficacy of Immune Checkpoint Inhibitors with Radiation in Advanced Non-Small-Cell Lung Cancer Patients: A Systematic Review and Meta-Analysis.

Huilin Xu, Dedong Cao, Dingjie Zhou

|May 05, 2022
The efficacy and safety of anlotinib for subsequent line treatment of small cell lung cancer: a systematic review and meta-analysis.

Huilin Xu, Dedong Cao, Fangfang Jie

|Nov 30, 2019
The Impact of Javanica Oil Emulsion Injection on Chemotherapy Efficacy and Cellular Immune Indicators in Patients with Advanced NSCLC: A Systematic Review and Meta-Analysis.

Huilin Xu, Zhucheng Yin, Anbing He

Pageof 1

Frequent Collaborators

2 joint publications

Dedong Cao

1 joint publications

Dingjie Zhou

1 joint publications

Anbing He

1 joint publications

Wei Ge